Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.
(Q45198729)
scientific article published in December 2004
scientific article published in December 2004
Language:
other details
| description | scientific article published in December 2004 |
External Links
| (P356) |
10.1021/JM049486A
|
| (P698) |
15615512
|